Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sick Leave | 4 | 2020 | 111 | 2.580 |
Why?
|
| Prostatic Neoplasms | 14 | 2023 | 10884 | 1.360 |
Why?
|
| Insurance, Disability | 2 | 2019 | 25 | 1.250 |
Why?
|
| Sweden | 9 | 2020 | 1321 | 0.940 |
Why?
|
| Pensions | 2 | 2020 | 14 | 0.910 |
Why?
|
| DNA Repair-Deficiency Disorders | 1 | 2021 | 28 | 0.840 |
Why?
|
| Prostatectomy | 4 | 2020 | 1846 | 0.760 |
Why?
|
| Women, Working | 1 | 2018 | 86 | 0.600 |
Why?
|
| Prostate | 4 | 2023 | 1679 | 0.590 |
Why?
|
| Watchful Waiting | 1 | 2020 | 475 | 0.550 |
Why?
|
| Breast Neoplasms | 4 | 2022 | 20448 | 0.440 |
Why?
|
| DNA Repair | 1 | 2021 | 2047 | 0.430 |
Why?
|
| Lymph Node Excision | 1 | 2018 | 1220 | 0.410 |
Why?
|
| Occupational Diseases | 1 | 2019 | 1466 | 0.380 |
Why?
|
| Erectile Dysfunction | 1 | 2014 | 466 | 0.380 |
Why?
|
| Drug Prescriptions | 2 | 2021 | 1624 | 0.350 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2022 | 17354 | 0.250 |
Why?
|
| 5-alpha Reductase Inhibitors | 1 | 2022 | 108 | 0.200 |
Why?
|
| Fanconi Anemia | 1 | 2021 | 321 | 0.170 |
Why?
|
| Melanoma | 2 | 2014 | 5358 | 0.170 |
Why?
|
| DNA Mismatch Repair | 1 | 2021 | 427 | 0.170 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 38748 | 0.160 |
Why?
|
| Multifactorial Inheritance | 2 | 2022 | 1148 | 0.160 |
Why?
|
| Food Supply | 1 | 2023 | 495 | 0.160 |
Why?
|
| Male | 17 | 2023 | 347096 | 0.140 |
Why?
|
| Risk Factors | 6 | 2023 | 71009 | 0.140 |
Why?
|
| Seminal Vesicles | 1 | 2016 | 104 | 0.140 |
Why?
|
| Cohort Studies | 5 | 2020 | 39918 | 0.140 |
Why?
|
| Receptors, Progesterone | 1 | 2020 | 1096 | 0.130 |
Why?
|
| Prediabetic State | 1 | 2020 | 476 | 0.130 |
Why?
|
| Prostate-Specific Antigen | 2 | 2022 | 2354 | 0.120 |
Why?
|
| Humans | 23 | 2023 | 725187 | 0.120 |
Why?
|
| Middle Aged | 9 | 2022 | 212292 | 0.120 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 11968 | 0.110 |
Why?
|
| Databases, Factual | 2 | 2019 | 7683 | 0.110 |
Why?
|
| Radiotherapy | 1 | 2020 | 1543 | 0.110 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2014 | 253 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 2168 | 0.100 |
Why?
|
| Mastectomy | 1 | 2020 | 1753 | 0.100 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2020 | 1513 | 0.100 |
Why?
|
| Age of Onset | 1 | 2018 | 3263 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2023 | 3166 | 0.100 |
Why?
|
| Life Style | 1 | 2022 | 3780 | 0.090 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 2335 | 0.090 |
Why?
|
| Age Factors | 2 | 2022 | 18339 | 0.080 |
Why?
|
| Cause of Death | 1 | 2019 | 3564 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2014 | 1488 | 0.080 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3172 | 0.070 |
Why?
|
| Aged | 6 | 2022 | 161486 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2023 | 23185 | 0.070 |
Why?
|
| Dementia | 1 | 2020 | 2384 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 10950 | 0.070 |
Why?
|
| Anxiety | 1 | 2020 | 4079 | 0.070 |
Why?
|
| Registries | 3 | 2020 | 7898 | 0.070 |
Why?
|
| Prognosis | 3 | 2022 | 28737 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2014 | 5479 | 0.060 |
Why?
|
| Preoperative Care | 1 | 2014 | 2265 | 0.060 |
Why?
|
| Adult | 6 | 2023 | 211615 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2020 | 4160 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2018 | 10251 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2022 | 15420 | 0.060 |
Why?
|
| Puerto Rico | 1 | 2023 | 349 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 57656 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 5522 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2022 | 21591 | 0.050 |
Why?
|
| Female | 6 | 2020 | 375449 | 0.050 |
Why?
|
| Depression | 1 | 2020 | 7454 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 11324 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2019 | 6436 | 0.040 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 2957 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2022 | 1588 | 0.030 |
Why?
|
| Death Certificates | 1 | 2014 | 168 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 40186 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 12329 | 0.030 |
Why?
|
| Incidence | 2 | 2023 | 20750 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2023 | 1826 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 1328 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2023 | 2651 | 0.030 |
Why?
|
| Emotions | 1 | 2023 | 2569 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 55781 | 0.020 |
Why?
|
| Adolescent | 2 | 2014 | 84401 | 0.020 |
Why?
|
| Risk | 1 | 2020 | 9700 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10247 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2020 | 6217 | 0.020 |
Why?
|
| United States | 2 | 2023 | 68403 | 0.020 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 5086 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6537 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1965 | 442 | 0.010 |
Why?
|
| Quality Control | 1 | 1965 | 847 | 0.010 |
Why?
|
| Biometry | 1 | 1965 | 560 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1965 | 2387 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 29672 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2021 | 61761 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 74206 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 28145 | 0.010 |
Why?
|
Concepts
(95)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_